These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The advantages of aminolevulinic acid photodynamic therapy in dermatology. Taylor EL; Brown SB J Dermatolog Treat; 2002; 13 Suppl 1():S3-11. PubMed ID: 12060511 [TBL] [Abstract][Full Text] [Related]
3. Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma. Hirschberg H; Spetalen S; Carper S; Hole P; Tillung T; Madsen S Minim Invasive Neurosurg; 2006 Jun; 49(3):135-42. PubMed ID: 16921452 [TBL] [Abstract][Full Text] [Related]
4. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Bisland SK; Lilge L; Lin A; Rusnov R; Wilson BC Photochem Photobiol; 2004; 80():22-30. PubMed ID: 15339204 [TBL] [Abstract][Full Text] [Related]
6. Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid. Tetard MC; Vermandel M; Mordon S; Lejeune JP; Reyns N Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):319-30. PubMed ID: 24905843 [TBL] [Abstract][Full Text] [Related]
7. The use of photodynamic therapy in dermatology: results of a consensus conference. Nestor MS; Gold MH; Kauvar AN; Taub AF; Geronemus RG; Ritvo EC; Goldman MP; Gilbert DJ; Richey DF; Alster TS; Anderson RR; Bank DE; Carruthers A; Carruthers J; Goldberg DJ; Hanke CW; Lowe NJ; Pariser DM; Rigel DS; Robins P; Spencer JM; Zelickson BD J Drugs Dermatol; 2006 Feb; 5(2):140-54. PubMed ID: 16485882 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825 [TBL] [Abstract][Full Text] [Related]
11. Aminolevulinic acid photodynamic therapy: medical evidence for its expanded use. Gold MH Expert Rev Med Devices; 2006 May; 3(3):357-71. PubMed ID: 16681457 [TBL] [Abstract][Full Text] [Related]
12. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis. Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Bogaards A; Varma A; Zhang K; Zach D; Bisland SK; Moriyama EH; Lilge L; Muller PJ; Wilson BC Photochem Photobiol Sci; 2005 May; 4(5):438-42. PubMed ID: 15875077 [TBL] [Abstract][Full Text] [Related]
14. Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy. Moriyama EH; Bisland SK; Lilge L; Wilson BC Photochem Photobiol; 2004; 80(2):242-9. PubMed ID: 15362932 [TBL] [Abstract][Full Text] [Related]
15. Current treatments of actinic keratosis. Gold MH; Nestor MS J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of newly implanted glioma cells in the rat brain. Madsen SJ; Angell-Petersen E; Spetalen S; Carper SW; Ziegler SA; Hirschberg H Lasers Surg Med; 2006 Jun; 38(5):540-8. PubMed ID: 16392143 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L; Wilson BC J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099 [TBL] [Abstract][Full Text] [Related]
18. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. Angell-Petersen E; Spetalen S; Madsen SJ; Sun CH; Peng Q; Carper SW; Sioud M; Hirschberg H J Neurosurg; 2006 Jan; 104(1):109-17. PubMed ID: 16509154 [TBL] [Abstract][Full Text] [Related]
19. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]